ibi351,cetuximab,GFH925
innovent biologics,Zhejiang genfleet therapeutics,eli lilly
['rectal', 'colorectal', 'ibi351', 'innovent']
dcbn news: innovent presents phase 1 clinical data of ibi351 (krasg12c inhibitor) as monotherapy for metastatic colorectal cancer at the 2023 asco annual meeting: rockville, md. and suzhou, china, june 5, 2023 ... #biotech #news 
Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.